(Q44961025)

7 December 2017

title

Breast cancer in young women in a limited-resource environment (English)

1 reference

7 December 2017

Sarinah Basro

1

1 reference

7 December 2017

Justus P Apffelstaedt

series ordinal

2

1 reference

7 December 2017

publication date

1 July 2010

1 reference

7 December 2017

published in

World Journal of Surgery

1 reference

7 December 2017

volume

34

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1427-1433

1 reference

https://scigraph.springernature.com/pub.10.1007/s00268-009-0299-5

7 December 2017

exact match

0 references

cites work

BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00268-009-0299-5

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

21 January 2018

1 reference

12 December 2020

Medical and radiation oncology for breast cancer in developing countries with particular reference to locally advanced breast cancer

1 reference

12 December 2020

Effect of social class disparities on disease stage, quality of treatment and survival outcomes in breast cancer patients from developing countries

1 reference

12 December 2020

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

1 reference

12 December 2020

Special issues related to the adjuvant therapy in very young women.

1 reference

12 December 2020

Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer

1 reference

12 December 2020

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age.

1 reference

12 December 2020

Treatment of breast cancer in countries with limited resources.

1 reference

12 December 2020

Breast cancer incidence and determinants of cancer stage in the Western Cape.

1 reference

12 December 2020

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

1 reference

12 December 2020

Breast cancer in Chinese women younger than age 40: are they different from their older counterparts?

1 reference

12 December 2020

BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer

1 reference

12 December 2020

The severity, outcome and challenges of breast cancer in Nigeria

1 reference

12 December 2020

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

12 December 2020

Factors influencing the effect of age on prognosis in breast cancer: population based study

1 reference

12 December 2020

Case-controlled study of the epidemiological risk factors for breast cancer in Nigeria

1 reference

12 December 2020

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives

1 reference

12 December 2020

Prognostic significance of young age in breast cancer

1 reference

12 December 2020

BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors

1 reference

12 December 2020

Stage 0 to stage III breast cancer in young women

1 reference

12 December 2020

Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience

1 reference

12 December 2020

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

1 reference

12 December 2020

Breast Surgery International--breast cancer in developing countries

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

Breast cancer incidence in South Africa

1 reference

12 December 2020

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

1 reference

12 December 2020

Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer

1 reference

12 December 2020

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

12 December 2020

Breast cancer in limited-resource countries: treatment and allocation of resources

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

12 December 2020

Breast cancer in sub-Saharan African women.

1 reference

12 December 2020

Breast cancer and conservative surgery in sub Saharan Africa

1 reference

12 December 2020

Breast cancer in black African women: a changing situation.

1 reference

12 December 2020

BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer

1 reference

12 December 2020

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

1 reference

12 December 2020

Spectrum of breast cancer in Asian women

1 reference

12 December 2020

Breast Cancer in Limited-Resource Countries: Early Detection and Access to Care

1 reference

12 December 2020

Clinical Breast Examination: What Can Be Recommended for Its Use to Detect Breast Cancer in Countries with Limited Resources?

1 reference

12 December 2020

The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age.

1 reference

12 December 2020

Why are local recurrences after breast-conserving therapy more frequent in younger patients?

1 reference

12 December 2020

Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease

1 reference

12 December 2020

Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer

1 reference

12 December 2020

Long-term outcome in women less than 30 years of age with breast cancer

1 reference

12 December 2020

Neoadjuvant trastuzumab induces apoptosis in primary breast cancers

1 reference

12 December 2020

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

1 reference

12 December 2020

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

12 December 2020

Breast cancer in limited-resource countries: health care systems and public policy

1 reference

12 December 2020

Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study

1 reference

12 December 2020

Mammary recurrences in women younger than forty

1 reference

12 December 2020

Younger women with breast carcinoma have a poorer prognosis than older women

1 reference

12 December 2020

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

1 reference

12 December 2020

BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families

1 reference

12 December 2020

Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study

1 reference

12 December 2020

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

12 December 2020

10.1007/S00268-009-0299-5

Identifiers

DOI

1 reference

7 December 2017

1 reference